QVAR
® (beclomethasone dipropionate HFA) Inhalation Aerosol is used in the ongoing treatment of asthma as preventative therapy in patients 5 years of age or older.
QVAR
® is also used for asthma patients who require systemic corticosteroid administration, where adding QVAR
® may reduce or eliminate the need for systemic corticosteroids.
QVAR
® does not replace quick-relief inhalers for sudden symptoms.
CAUTION: If you are stopping or switching from an oral corticosteroid to QVAR®, follow your doctor's instructions to avoid health risks. (See WARNINGS, Prescribing Information).
Inhaled corticosteroids may cause a reduction in growth rate, so children taking QVAR
® should have their growth checked regularly. The long-term effect on final adult growth is unknown.
Do not stop taking QVAR
® abruptly without talking to your doctor.
In clinical studies, common side effects included headache and sore throat. These are not all of the possible side effects of QVAR
®. For more information, ask your healthcare provider or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call
1-800-FDA-1088.
QVAR® is a registered trademark of IVAX LLC, a member of the Teva Group.
©2012 Teva Respiratory, LLC. This site is intended for U.S. residents only.